RD14-01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RD14-01, covering 2023-03-01 to 2023-03-01. Get the full timeline:
Most recent: Clinical Trial Update: A Study of RD14-01 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]